AtriCure announced that the first patient was treated in the Left Atrial Appendage Exclusion for Stroke Prevention, or LeAAPS, clinical trial. The patient was treated by U.S. co-principal investigator Marc Gerdisch at Franciscan St. Francis Heart Center in Indianapolis, Indiana.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ATRC: